LITTLE FALLS, N.J.,
Oct. 21, 2011 /PRNewswire/ --
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that its
Board of Directors approved an increase in its semiannual cash
dividend to $0.07 per outstanding
share of the Company's Common Stock. The dividend is payable on
January 31, 2012 to shareholders of
record at the close of business on January
17, 2012.
Charles M. Diker, Chairman of the
Board, said, "We are pleased to announce the dividend increase,
which will raise our annual dividend payment from $0.12 to $0.14 per
share. The increase demonstrates Cantel's strong financial position
and our confidence in Cantel's future performance."
Cantel Medical Corp. (NYSE: CMN) is a leading provider of
infection prevention and control products in the healthcare market.
Our products include water purification equipment, sterilants,
disinfectants and cleaners, specialized medical device reprocessing
systems for endoscopy and renal dialysis, disposable infection
control products primarily for the dental industry, dialysate
concentrates and other dialysis supplies, hollow fiber membrane
filtration and separation products for medical and non-medical
applications, and specialty packaging for infectious and biological
specimens. We also provide technical maintenance for our products
and offer compliance training services for the transport of
infectious and biological specimens.
For further information, visit the Cantel website at
www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.